Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Cancer Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Wencheng Zhang, M.D.) · zhangwencheng@tjmuch.com · 02223340123

Study leads

Wencheng Zhang, M.D.
Principal Investigator
Tianjin Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Esophageal Cancer · Oesophageal Cancer · GastroEsophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Milwaukee, United States

MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC) · Esophageal Cancer, Squamous Cell

Abroad (travel likely)RecruitingPHASE1

Utrecht, Netherlands

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumor · Melanoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · New Haven, United States

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Advanced/Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · Los Angeles, United States